Dr. Aaron Waxman provides an overview of accurate diagnosis and therapeutic options to manage symptoms in patients with pulmonary arterial hypertension. Medscape Pulmonary Medicine
Over the 2-year study period, oncology, endocrinology, and rheumatology had more registered study protocols in the second year than the first, whereas studies in cardiology declined from 346 registered protocols in year 1 to 257 registered studies in the second year. Medscape Medical News
With more data about Vytorin and ezetimibe being presented at the European cardiology meeting, in this video blog Dr. Black discusses what we should think about the results, given their context. Medscape Cardiology
Results from the largest secondary stroke-prevention trial showed that the combination of aspirin and extended-release dipyridamole did not meet criteria for noninferiority vs clopidogrel. In a factorial design, results also showed no effect of telmisartan vs placebo in reducing recurrent stroke, major CVD events, or diabetes. Medscape Medical News
The US FDA has approved a diagnostic blood test, AlloMap, to help identify heart-transplant recipients who might be at risk of organ rejection. One expert says the test has reduced invasive biopsies by up to 75% at his center. Heartwire
In premature infants, neonatal treatment of lung disease with dexamethasone or hydrocortisone and antenatal treatment with dexamethasone had no adverse effects on heart rate and blood pressure. Medscape Medical News
Learn the most up-to-date information regarding the diagnosis, management, and prevention of VTE using interactive case simulations. Medscape Neurology & Neurosurgery
Dr. Karas educates readers about risk factors for CVD, predicting CVD risk, and managing high lipid levels in patients with existing CVD. Medscape Cardiology
